Metraipolis › archive › dc_df211900bc3c

IL12B rs3213094 as a Predictor of Early Response to Biologic Therapy in Psoriasis: A Real-World Study in a Romanian Cohort — Europe PMC PMID:42356054

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42356054
DOI
10.3390/medicina62061041
License (as archived)
solo-consultazione
Archived
2026-11-01T05:20:38.886Z
SHA-256 of the archived text
402dcc8ad61440a2236ec6c30d6addd732561957d0b30fb3a6e7a65dd1d8473f
Stable URL of this page
https://metraipolis.com/documento/dc_df211900bc3c

How to cite

IL12B rs3213094 as a Predictor of Early Response to Biologic Therapy in Psoriasis: A Real-World Study in a Romanian Cohort — Europe PMC PMID:42356054 — Europe PMC (en), https://europepmc.org/article/MED/42356054 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_df211900bc3c (Metraipolis archive dc_df211900bc3c, sha256 402dcc8ad61440a2236ec6c30d6addd732561957d0b30fb3a6e7a65dd1d8473f)
BibTeX
@misc{dcdf211900bc3c,
  title = {IL12B rs3213094 as a Predictor of Early Response to Biologic Therapy in Psoriasis: A Real-World Study in a Romanian Cohort — Europe PMC PMID:42356054},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42356054},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_df211900bc3c; sha256 402dcc8ad61440a2236ec6c30d6addd732561957d0b30fb3a6e7a65dd1d8473f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42356054. Agents can read the archived copy with the MCP tool read_document.